Charles River Laboratories (CRL)
Quick ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | US$ in thousands | 276,771 | 157,174 | 200,445 | 201,587 | 233,912 | 193,701 | 200,321 | 241,869 | 241,214 | 212,539 | 222,969 | 465,411 | 228,424 | 242,879 | 402,020 | 372,433 | 238,014 | 164,759 | 200,589 | 126,316 |
Short-term investments | US$ in thousands | — | 944 | 951 | 1,001 | 998 | 950 | 1,012 | 1,065 | 1,063 | 1,030 | 1,037 | 1,025 | 1,024 | 963 | 929 | 934 | 941 | 855 | 887 | 907 |
Receivables | US$ in thousands | 780,375 | 799,310 | 800,646 | — | 752,390 | 778,499 | 755,343 | 706,796 | 650,381 | 660,452 | 644,027 | 610,566 | 617,740 | 572,058 | 532,531 | 542,390 | 514,033 | 524,074 | 545,148 | 495,501 |
Total current liabilities | US$ in thousands | 1,055,080 | 993,816 | 1,007,620 | 981,392 | 1,091,580 | 1,014,190 | 1,048,140 | 993,839 | 1,033,180 | 983,751 | 929,610 | 803,376 | 839,751 | 787,014 | 727,936 | 690,896 | 710,181 | 681,646 | 635,598 | 529,759 |
Quick ratio | 1.00 | 0.96 | 0.99 | 0.21 | 0.90 | 0.96 | 0.91 | 0.96 | 0.86 | 0.89 | 0.93 | 1.34 | 1.01 | 1.04 | 1.29 | 1.33 | 1.06 | 1.01 | 1.17 | 1.18 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($276,771K
+ $—K
+ $780,375K)
÷ $1,055,080K
= 1.00
The quick ratio of Charles River Laboratories has varied over the past quarters, ranging from as low as 0.21 to as high as 1.34. A quick ratio of 1.00 indicates that the company's current assets, excluding inventory, are sufficient to cover its current liabilities.
In the most recent quarter, the quick ratio was 0.96, suggesting that the company may face some liquidity challenges in meeting its short-term obligations without relying on selling off inventory. However, the company's quick ratio has generally been above 1.00 in previous quarters, indicating a stronger ability to cover short-term liabilities without relying heavily on inventory.
Overall, the trend in the quick ratio for Charles River Laboratories appears relatively stable, with occasional fluctuations. It is important for the company to monitor its liquidity position closely to ensure it can meet its short-term financial obligations effectively.
Peer comparison
Dec 31, 2023